Header Logo

Connection

RITSUKO KOMAKI to Bevacizumab

Back to Details
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Bevacizumab.
RITSUKO KOMAKI
Connection Strength
0.015
Bevacizumab
  1. ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. J Am Coll Radiol. 2009 Feb; 6(2):85-95.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.